All of the programmes within our department have a strong emphasis on professionalism and patient centred outcomes.
We partner closely with the NHS, pharmaceutical and biotech industries to ensure all of our students benefit from programmes designed to meet the ever-changing demands of their future employers.
A wide range of NHS practitioners and industry professionals are involved in the design and teaching of all of our programmes ensuring they keep up to date with the latest issues and challenges faced in the real world of employment.
The department invests heavily in student placements from the very beginning of most degree programmes and uses a clinical simulation to allow students to practise their skills in a safe environment before they come in to contact with real patients. Inter-professional working and collaboration is a central theme of the department.
The University has invested heavily and continues to do so to ensure that the department has the latest state of the art facilities and equipment to deliver cutting edge teaching, training and research. In September 2015 the department will be moving in to the brand new £50m Science Building.
The department has a thriving research community focused around topical drug delivery and toxicology, pharmacology and patient safety. 72% of our research was recently classed as internationally or nationally excellent.
This year we are celebrating 10 years of the MPharm degree at Hertfordshire and are launching our re-vamped Pharmaceutical Science degree and our brand new innovative integrated Masters in optometry.
The research interests of the pharmaceutics group are focused on drug delivery to the skin, lungs, other mucosal tissues, nanopharmaceutics and toxicology.
Within the pharmaceutics group projects are currently being funded by the:
Research also contributes significantly to the MPharm programme via the Research Methods and Research Project modules, which integrates teaching and research and also allows many pharmaceutics project students to complete a project in conjunction with an industrial partner.